• Working Hours - Mon - Fri: 9:30 - 18:30
Prazosin Hydrochloride Sustained Release Tablets 2.5 mg (Prazonift 2.5XL)

Prazosin Hydrochloride Sustained Release Tablets 2.5 mg (Prazonift 2.5XL)

Prazonift 2.5XL by Curavax Pharmaceuticals Pvt. Ltd. is a Pharmaceutical product containing Prazosin Hydrochloride Sustained Release (SR) 2.5 mg. Prazosin belongs to the class of medicines known as alpha-1 adrenergic receptor blockers.

Contact Details

Address:
Khasra No. 8/6, 15/1, Plot No. 8, Kuldeep Nagar, Ambala Cantt., Haryana

Phone: +91-89503-29008

Email: curavax@gmail.com

Product Information

Particular Details
Brand Name Prazonift 2.5XL
Composition Prazosin Hydrochloride 2.5 mg
Dosage Form Sustained Release Tablet
Strength 2.5 mg
Therapeutic Class Alpha-1 Adrenergic Blocker
Company Curavax Pharmaceuticals Pvt. Ltd.
Route of Administration Oral

Why Choose Curavax Pharmaceuticals?

Curavax Pharmaceuticals Pvt. Ltd. is an Indian pharmaceutical company involved in pharmaceutical products and PCD Pharma Franchise opportunities. Prazonift 2.5XL is one of the products associated with Curavax Pharmaceuticals Pvt. Ltd., providing a branded option containing Prazosin Hydrochloride Sustained Release 2.5 mg.

What is Prazosin Hydrochloride (Prazonift 2.5XL)?

Prazosin Hydrochloride (Prazonift 2.5XL) is an alpha-1 adrenergic receptor antagonist. By blocking postsynaptic alpha-1 receptors, it reduces the constriction of blood vessels. This produces vasodilation and can lower blood pressure. Alpha-1 receptors are also present in smooth muscle around the prostate and bladder neck which explains why prazosin has been studied and used for urinary symptoms associated with benign prostatic hyperplasia (BPH).

Prazonift 2.5XL Uses

Prazosin (Prazonift 2.5XL) is primarily established as an antihypertensive medicine. Depending on the formulation, country and prescribing information prazosin may also be used for other clinical conditions under medical supervision.

1. Hypertension

Prazosin (Prazonift 2.5XL) can help lower elevated blood pressure by relaxing vascular smooth muscle and reducing systemic vascular resistance. It may be prescribed alone or alongside other antihypertensive medicines when clinically appropriate.

2. Urinary Symptoms Associated With BPH

Alpha-1 blockers relax smooth muscle in the prostate and bladder neck, which can reduce resistance to urinary flow. Prazosin has been investigated and used for BPH-related urinary symptoms although treatment choice depends on the patient’s individual condition and current clinical guidance.

3. Other Medical Uses

Prazosin is also used in some settings for conditions such as PTSD associated nightmares but these uses may be off-label depending on the jurisdiction and should only be undertaken under appropriate medical supervision.

Mechanism of Action

Normally stimulation of these receptors by catecholamines can cause contraction of vascular smooth muscle and vasoconstriction. Prazosin blocks this response resulting in:

  • Relaxation of vascular smooth muscle
  • Reduced peripheral vascular resistance
  • Improved blood flow
  • Reduction in blood pressure

Why Sustained Release?

Prazonift 2.5XL is presented as a sustained-release formulation. Sustained release dosage forms are designed to release medicine over an extended period rather than delivering the entire dose immediately.

Prazonift 2.5XL Side Effects

Like other medicines prazosin may cause side effects. Commonly reported effects can include:

  • Dizziness
  • Headache
  • Weakness or tiredness
  • Drowsiness
  • Nausea
  • Palpitations

Important Precautions

Patients taking Prazonift 2.5XL should inform their doctor about all medicines and supplements they use.

  • Low blood pressure
  • A history of dizziness or fainting
  • Liver disease
  • Cataracts or planned cataract surgery
  • Other cardiovascular conditions
  • Medicines that can further lower blood pressure

Prazosin and First Dose Hypotension

One of the clinically important features of prazosin is the possibility of first-dose hypotension. A sudden reduction in blood pressure can cause dizziness or fainting, and the risk may increase with rapid dose escalation or the addition of other blood-pressure-lowering medicines.

Prazonift 2.5XL – Role in Pharmaceutical Therapy

Prazonift 2.5XL combines the established pharmacological activity of prazosin with a sustained-release dosage form. Its therapeutic role is primarily associated with alpha-1 adrenergic blockade and blood-pressure reduction.

For patients who require prazosin therapy, the choice of immediate-release or sustained-release formulation should be based on the approved formulation, clinical indication, dosing requirements, and physician’s assessment.

Storage Information

Store the medicine according to the storage instructions provided on the product packaging. Keep tablets in their original container, protected from excessive heat and moisture, and out of reach of children.

Frequently Asked Questions

What is Prazonift 2.5XL?

Prazonift 2.5XL is a brand of Prazosin Hydrochloride Sustained Release 2.5 mg Tablets from Curavax Pharmaceuticals Pvt. Ltd.

What is Prazonift 2.5XL used for?

Prazosin is primarily used for the management of hypertension. Prazosin may also be used for certain other conditions under medical supervision, including some urinary symptoms associated with BPH.

What is the composition of Prazonift 2.5XL?

Prazonift 2.5XL contains Prazosin Hydrochloride 2.5 mg in a sustained-release tablet formulation.

Is Prazonift 2.5XL a blood-pressure medicine?

Yes. Prazosin is an alpha-1 adrenergic blocker with antihypertensive activity and can be prescribed for hypertension.

Can Prazonift 2.5XL cause dizziness?

Yes. Dizziness and postural hypotension are recognized effects of prazosin. Patients should be particularly careful when standing up suddenly, especially when beginning treatment.

Can the tablet be crushed?

For sustained-release/GITS formulations, tablets may need to be swallowed whole. The specific instructions supplied with Prazonift 2.5XL should be followed; do not crush, chew, or divide the tablet unless the product information specifically permits it.

Conclusion

Prazonift 2.5XL – Prazosin Hydrochloride Sustained Release Tablets 2.5 mg, from Curavax Pharmaceuticals Pvt. Ltd., is an alpha-1 adrenergic blocker formulation. Prazosin lowers blood pressure by relaxing vascular smooth muscle and may have additional clinical applications under appropriate medical supervision. Because hypotension, dizziness, and fainting can occur, treatment should be individualized and used according to a healthcare professional’s advice.

Call Now
Whatsapp
Scroll to Top